Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation

Journal of Biological Chemistry

Volumn 289, Issue 42, 2014, Pages 29074-29085

  Chakraborty, Samik ^a   Das, Kaushik ^a   Saha, Shilpi ^a   Mazumdar, Minakshi ^a   Manna, Argha ^a   Chakraborty, Sreeparna ^a   Mukherjee, Shravanti ^a   Khan, Poulami ^a   Adhikary, Arghya ^a   Mohanty, Suchismita ^a   Chattopadhyay, Samit ^b   Biswas, Subhash C ^c   Sa, Gaurisankar ^a   Das, Tanya ^a  

^a BOSE INSTITUTE   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; CELL DEATH; CHROMOSOMES; DISEASES; PROTEINS;

APOPTOTIC; CERVICAL CANCERS; CURCUMIN; DEACETYLATION; NUCLEAR MATRIX; THERAPEUTIC TARGETS;

TRANSCRIPTION;

ACYLTRANSFERASE; CURCUMIN; HISTONE DEACETYLASE 1; HISTONE H3; NUCLEAR MATRIX PROTEIN; PROTEIN C FOS; PROTEIN E6; PROTEIN P53; SMAR1 PROTEIN; TIP60 PROTEIN; UNCLASSIFIED DRUG; BANP PROTEIN, HUMAN; CELL CYCLE PROTEIN; CHROMATIN; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; HISTONE; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN BINDING; TRANSCRIPTION FACTOR AP 1;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CERVICAL ADENOCARCINOMA; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; CONTROLLED STUDY; DEACETYLATION; GENE SEQUENCE; HISTONE ACETYLATION; HISTONE DEACETYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; MATRIX ATTACHMENT REGION; PROMOTER REGION; PROTEIN ACETYLATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; TRANSACTIVATION; TRANSCRIPTION TERMINATION; UPREGULATION; UTERINE CERVIX CARCINOMA; ACETYLATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HELA CELL LINE; METABOLISM;

ACETYLATION; APOPTOSIS; CELL CYCLE PROTEINS; CHROMATIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HISTONES; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 84908190496     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.564872     Document Type: Article

References (43)

1. Beaudenon, S., and Huibregtse, J. M. (2008) HPV E6, E6AP and cervical cancer. BMC Biochem. 9, S4.
2. Burd, E. M. (2003) Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16, 1-17.
3. Parazzini, F., and La Vecchia, C. (1990) Epidemiology of adenocarcinoma of the cervix. Gynecol. Oncol. 39, 40-46.
4. Ferguson, A. W., Svoboda-Newman, S. M., and Frank, T. S. (1998) Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod. Pathol. 11, 11-18.
5. Tenti, P., Pavanello, S., Padovan, L., Spinillo, A., Vesentini, N., Zappatore, R., Migliora, P., Zara, C., Ranzani, G. N., and Carnevali, L. (1998) Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix. Am. J. Pathol. 152, 1057-1063.
6. Yamakawa, Y., Forslund, O., Teshima, H., Hasumi, K., Kitagawa, T., and Hansson, B. G. (1994) Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction. Gynecol. Oncol. 53, 190-195.
7. Mahata, S., Bharti, A. C., Shukla, S., Tyagi, A., Husain, S. A., and Das, B. C. (2011) Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol. Cancer 10, 39.
8. de Wilde, J., De-Castro Arce, J., Snijders, P. J., Meijer, C. J., Rösl, F., and Steenbergen, R. D. (2008) Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell Oncol. 30, 77-87.
9. Wang, W. M., Wu, S. Y., Lee, A. Y., and Chiang, C. M. (2011) Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription. J. Biol. Chem. 286, 40974-40986.
10. Subbaramaiah, K., and Dannenberg, A. J. (2007) Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange. Cancer Res. 67, 3976-3985.
11. Amortegui, A. J., Meyer, M. P., Elborne, V. L., and Amin, R. M. (1995) p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus DNA-positive cervical intraepithelial neoplasia and invasive cancer. Mod. Pathol. 8, 907-912.
12. Thomas, M. C., and Chiang, C. M. (2005) E6 oncoprotein represses p53- dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol. Cell 17, 251-264.
13. Klingelhutz, A. J., Foster, S. A., and McDougall, J. K. (1996) Telomerase activation by the E6 gene product of human papilloma virus type 16. Nature 380, 79-82.
14. Dar, A., Shibata, E., and Dutta, A. (2013) Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol. Cell. Biol. 33, 3309-3320.
15. Jha, S., Vande Pol, S., Banerjee, N. S., Dutta, A. B., Chow, L. T., and Dutta, A. (2010) Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway. Mol. Cell 38, 700-711.
16. Charvet, C., Wissler, M., Brauns-Schubert, P., Wang, S. J., Tang, Y., Sigloch, F. C., Mellert, H., Brandenburg, M., Lindner, S. E., Breit, B., Green, D. R., McMahon, S. B., Borner, C., Gu, W., and Maurer, U. (2011) Phos- phorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Mol. Cell 42, 584-596.
17. Rampalli, S., Pavithra, L., Bhatt, A., Kundu, T. K., and Chattopadhyay, S. (2005) Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol. Cell. Biol. 25, 8415-8429.
18. Singh, K., Mogare, D., Giridharagopalan, R. O., Gogiraju, R., Pande, G., and Chattopadhyay, S. (2007) p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion. PLoS One 2, e660.
19. Kaul, R., Mukherjee, S., Ahmed, F., Bhat, M. K., Chhipa, R., Galande, S., and Chattopadhyay, S. (2003) Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice. Int. J. Cancer 103, 606-615.
20. Jalota-Badhwar, A., Kaul-Ghanekar, R., Mogare, D., Boppana, R., Paknikar, K. M., and Chattopadhyay, S. (2007) SMAR1-derived P44 peptide retains its tumor suppressor function through modulation of p53. J. Biol. Chem. 282, 9902-9913.
21. Sreenath, K., Pavithra, L., Singh, S., Sinha, S., Dash, P. K., Siddappa, N. B., Ranga, U., Mitra, D., and Chattopadhyay, S. (2010) Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling. Virology 400, 76-85.
22. Sen, G. S., Mohanty, S., Hossain, D. M., Bhattacharyya, S., Banerjee, S., Chakraborty, J., Saha, S., Ray, P., Bhattacharjee, P., Mandal, D., Bhattacharya, A., Chattopadhyay, S., Das, T., and Sa, G. (2011) Curcumin enhances the efficacy of chemotherapy by tailoring p65NF-B-p300 cross-talk in favor of p53-p300 in breast cancer. J. Biol. Chem. 286, 42232-42247.
23. Singh, A. K., and Misra, K. (2013) Human papilloma virus 16 E6 protein as a target for curcuminoids, curcumin conjugates and congeners for chemoprevention of oral and cervical cancers. Interdiscip. Sci. 5, 112-118.
24. Shukla, S., Mahata, S., Shishodia, G., Pandey, A., Tyagi, A., Vishnoi, K., Basir, S. F., Das, B. C., and Bharti, A. C. (2013) Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. PLoS One 8, e67849.
25. Maher, D. M., Bell, M. C., O'Donnell, E. A., Gupta, B. K., Jaggi, M., and Chauhan, S. C. (2011) Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene- induced upregulation of HPV E7. Mol. Carcinog. 50, 47-57.
26. Saha, B., Adhikary, A., Ray, P., Saha, S., Chakraborty, S., Mohanty, S., Das, K., Mukherjee, S., Mazumdar, M., Lahiri, L., Hossain, D. M., Sa, G., and Das, T. (2012) Restoration of tumor suppressor p53 by differentially regulating pro- And anti-p53 networks in HPV-18-infected cervical cancer cells. Oncogene 31, 173-186.
27. Chakraborty, J., Banerjee, S., Ray, P., Hossain, D. M., Bhattacharyya, S., Adhikary, A., Chattopadhyay, S., Das, T., and Sa, G. (2010) Gain of cellular adaptation due to prolonged p53 impairment leads to functional switchover from p53 to p73 during DNA damage in acute myeloid leukemia cells. J. Biol. Chem. 285, 33104-33112.
28. Mohanty, S., Saha, S., Hossain, D. S., Adhikary, A., Mukherjee, S., Manna, A., Chakraborty, S., Mazumdar, M., Ray, P., Das, K., Chakraborty, J., Sa, G., and Das, T. (2014) ROS-PIAS- cross talk channelizesATMsignaling from resistance to apoptosis during chemosensitization of resistant tumors. Cell Death Dis. 5, e1021.
29. Kulkarni, A., Pavithra, L., Rampalli, S., Mogare, D., Babu, K., Shiekh, G., Ghosh, S., and Chattopadhyay, S. (2004) HIV-1 integration sites are flanked by potential MARs that alone can act as promoters. Biochem. Biophys. Res. Commun. 322, 672-677.
30. Malonia, S. K., Sinha, S., Lakshminarasimhan, P., Singh, K., Jalota-Badhwar, A., Rampalli, S., Kaul-Ghanekar, R., and Chattopadhyay, S. (2011) Gene regulation by SMAR1: role in cellular homeostasis and cancer. Biochim. Biophys. Acta 1815, 1-12.
31. Narechania, A., Chen, Z., DeSalle, R., and Burk, R. D. (2005) Phylogenetic incongruence among oncogenic genital α human papillomaviruses. J. Virol. 79, 15503-15510.
32. Sinha, S., Malonia, S. K., Mittal, S. P., Mathai, J., Pal, J. K., and Chattopadhyay, S. (2012) Chromatin remodelling protein SMAR1 inhibits p53 dependent transactivation by regulating acetyl transferase p300. Int. J. Biochem. Cell Biol. 44, 46-52.
33. Kehrmann, A., Truong, H., Repenning, A., Boger, R., Klein-Hitpass, L., Pascheberg, U., Beckmann, A., Opalka, B., and Kleine-Lowinski, K. (2013) Complementation of non-tumorigenicity of HPV18-positive cervical carcinoma cells involves differential mRNA expression of cellular genes including potential tumor suppressor genes on chromosome 11q13. Cancer Genet. 206, 279-292.
34. Kadamb, R., Mittal, S., Bansal, N., Batra, H., and Saluja, D. (2013) Sin3: insight into its transcription regulatory functions. Eur. J. Cell Biol. 92, 237-246.
35. Yasui, D., Miyano, M., Cai, S., Varga-Weisz, P., and Kohwi-Shigematsu, T. (2002) SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419, 641-645.
36. Zhang, X., Wharton, W., Yuan, Z., Tsai, S. C., Olashaw, N., and Seto, E. (2004) Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3. Mol. Cell. Biol. 24, 5106-5118.
37. MacLaine, N. J., Oster, B., Bundgaard, B., Fraser, J. A., Buckner, C., Lazo, P. A., Meek, D. W., Höllsberg, P., and Hupp, T. R. (2008) A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection. J. Biol. Chem. 283, 28563-28573.
38. Tang, Y., Luo, J., Zhang, W., and Gu, W. (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 24, 827-839.
39. Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., and McMahon, S. B. (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell. 24, 841-851.
40. Stünkel, W., Huang, Z., Tan, S. H., O'Connor, M. J., and Bernard, H. U. (2000) Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J. Virol. 74, 2489-2501.
41. Li, J. J., Rhim, J. S., Schlegel, R., Vousden, K. H., and Colburn, N. H. (1998) Expression of dominant negative Jun inhibits elevated AP-1 and NF-B transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene 16, 2711-2721.
42. Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., and Kundu, T. K. (2004) Curcumin, a novel p300/CREBbinding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279, 51163-51171.
43. Sinitsyna, N. N., Reznikova, T. V., Qin, Q., Song, H., Phillips, M. A., and Rice, R. H. (2010) Arsenite suppression of involucrin transcription through AP-1 promoter sites in cultured human keratinocytes. Toxicol. Appl. Pharmacol. 243, 275-282.